Literature DB >> 25093570

Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants.

Roy N Alcalay1, Jan Aasly2, Daniela Berg3, Susan Bressman4, Alexis Brice5, Kathrin Brockmann3, Piu Chan6, Lorraine Clark1, Florence Cormier5, Jean-Christophe Corvol5, Alexandra Durr5, Maurizio Facheris7, Matthew Farrer8, Tatiana M Foroud9, Thomas Gasser3, Nir Giladi10, Cheryl Halter9, Anthony Lang11, J William Langston12, Connie Marras11, Jose-Felix Marti-Masso13, Javier Ruiz Martinez13, Helen Mejia-Santana1, Anat Mirelman10, Claustre Pont-Sunyer14, Avi Orr-Urtreger10, Deborah Raymond4, Rachel Saunders-Pullman4, Birgitt Schüle12, Caroline Tanner12, Eduardo Tolosa14, Alison Urkowitz7, Dolores Vilas14, Adina Wise1, Karen Marder1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25093570      PMCID: PMC4682659          DOI: 10.1038/gim.2014.55

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  11 in total

1.  Genetic testing legislation in Western Europe-a fluctuating regulatory target.

Authors:  Sirpa Soini
Journal:  J Community Genet       Date:  2012-01-28

2.  LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs.

Authors:  Suzanne Lesage; Alexandra Dürr; Meriem Tazir; Ebba Lohmann; Anne-Louise Leutenegger; Sabine Janin; Pierre Pollak; Alexis Brice
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

3.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

Authors:  Laurie J Ozelius; Geetha Senthil; Rachel Saunders-Pullman; Erin Ohmann; Amanda Deligtisch; Michele Tagliati; Ann L Hunt; Christine Klein; Brian Henick; Susan M Hailpern; Richard B Lipton; Jeannie Soto-Valencia; Neil Risch; Susan B Bressman
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

4.  Kin-cohort analysis of LRRK2-G2019S penetrance in Parkinson's disease.

Authors:  Stefano Goldwurm; Sara Tunesi; Silvana Tesei; Michela Zini; Francesca Sironi; Paola Primignani; Corrado Magnani; Gianni Pezzoli
Journal:  Mov Disord       Date:  2011-06-28       Impact factor: 10.338

5.  Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism.

Authors:  Joanne Trinh; Rim Amouri; John E Duda; James F Morley; Matthew Read; Alan Donald; Carles Vilariño-Güell; Christina Thompson; Chelsea Szu Tu; Emil K Gustavsson; Samia Ben Sassi; Emna Hentati; Mourad Zouari; Emna Farhat; Fatma Nabli; Faycel Hentati; Matthew J Farrer
Journal:  Neurobiol Aging       Date:  2013-11-22       Impact factor: 4.673

6.  Clinical and pathological characteristics of LRRK2 G2019S patients with PD.

Authors:  Markos Poulopoulos; Etty Cortes; Jean-Paul G Vonsattel; Stanley Fahn; Cheryl Waters; Lucien J Cote; Carol Moskowitz; Lawrence S Honig; Lorraine N Clark; Karen S Marder; Roy N Alcalay
Journal:  J Mol Neurosci       Date:  2011-12-23       Impact factor: 3.444

7.  Knowledge of and interest in genetic results among Parkinson disease patients and caregivers.

Authors:  Karina Sakanaka; Cheryl H Waters; Oren A Levy; Elan D Louis; Wendy K Chung; Karen S Marder; Roy N Alcalay
Journal:  J Genet Couns       Date:  2013-06-09       Impact factor: 2.537

8.  Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease.

Authors:  Roy N Alcalay; Helen Mejia-Santana; Ming Xin Tang; Llency Rosado; Miguel Verbitsky; Sergey Kisselev; Barbara M Ross; Elan D Louis; Cynthia L Comella; Amy Colcher; Danna Jennings; Martha A Nance; Susan Bressman; William K Scott; Caroline Tanner; Susan F Mickel; Howard F Andrews; Cheryl H Waters; Stanley Fahn; Lucien J Cote; Steven J Frucht; Blair Ford; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald Pfeiffer; Laura Marsh; Bradley Hiner; Andrew Siderowf; Elise Caccappolo; Ruth Ottman; Lorraine N Clark; Karen S Marder
Journal:  Arch Neurol       Date:  2009-12

9.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.

Authors:  Daniel G Healy; Mario Falchi; Sean S O'Sullivan; Vincenzo Bonifati; Alexandra Durr; Susan Bressman; Alexis Brice; Jan Aasly; Cyrus P Zabetian; Stefano Goldwurm; Joaquim J Ferreira; Eduardo Tolosa; Denise M Kay; Christine Klein; David R Williams; Connie Marras; Anthony E Lang; Zbigniew K Wszolek; Jose Berciano; Anthony H V Schapira; Timothy Lynch; Kailash P Bhatia; Thomas Gasser; Andrew J Lees; Nicholas W Wood
Journal:  Lancet Neurol       Date:  2008-06-06       Impact factor: 44.182

10.  Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

Authors:  Coro Paisán-Ruíz; Shushant Jain; E Whitney Evans; William P Gilks; Javier Simón; Marcel van der Brug; Adolfo López de Munain; Silvia Aparicio; Angel Martínez Gil; Naheed Khan; Janel Johnson; Javier Ruiz Martinez; David Nicholl; Itxaso Martí Carrera; Amets Saénz Pena; Rohan de Silva; Andrew Lees; José Félix Martí-Massó; Jordi Pérez-Tur; Nick W Wood; Andrew B Singleton
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173

View more
  2 in total

Review 1.  Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.

Authors:  Maria Angeles Martinez-Grau; Maria Alvim-Gaston
Journal:  Pharmaceut Med       Date:  2019-06

2.  Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations.

Authors:  Claustre Pont-Sunyer; Susan Bressman; Deborah Raymond; Amanda Glickman; Eduardo Tolosa; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2015-05-07       Impact factor: 10.338

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.